These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21111714)

  • 1. The assessment of non-feminizing estrogens for use in neuroprotection.
    Yi KD; Perez E; Yang S; Liu R; Covey DF; Simpkins JW
    Brain Res; 2011 Mar; 1379():61-70. PubMed ID: 21111714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mechanism of non-feminizing estrogens in neuroprotection.
    Engler-Chiurazzi EB; Covey DF; Simpkins JW
    Exp Gerontol; 2017 Aug; 94():99-102. PubMed ID: 27818250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.
    Zhao L; Brinton RD
    BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-feminizing estrogens: a novel neuroprotective therapy.
    Petrone AB; Gatson JW; Simpkins JW; Reed MN
    Mol Cell Endocrinol; 2014 May; 389(1-2):40-7. PubMed ID: 24424441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties.
    Moosmann B; Behl C
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):8867-72. PubMed ID: 10430862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ICI 182,780-sensitive, membrane-related estrogen receptor contributes to estrogenic neuroprotective actions against amyloid-beta toxicity.
    Marin R; Guerra B; Morales A; Diaz M; Alonso R
    Ann N Y Acad Sci; 2003 Dec; 1007():108-16. PubMed ID: 14993045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection with non-feminizing estrogen analogues: an overlooked possible therapeutic strategy.
    Simpkins JW; Richardson TE; Yi KD; Perez E; Covey DF
    Horm Behav; 2013 Feb; 63(2):278-83. PubMed ID: 22498694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor-independent neuroprotection via protein phosphatase preservation and attenuation of persistent extracellular signal-regulated kinase 1/2 activation.
    Yi KD; Cai ZY; Covey DF; Simpkins JW
    J Pharmacol Exp Ther; 2008 Mar; 324(3):1188-95. PubMed ID: 18089844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity studies of non-steroid analogues structurally-related to neuroprotective estrogens.
    Qian M; Engler-Chiurazzi EB; Lewis SE; Rath NP; Simpkins JW; Covey DF
    Org Biomol Chem; 2016 Oct; 14(41):9790-9805. PubMed ID: 27714297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection.
    Cardona-Gómez GP; Mendez P; DonCarlos LL; Azcoitia I; Garcia-Segura LM
    Brain Res Brain Res Rev; 2001 Nov; 37(1-3):320-34. PubMed ID: 11744097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in Vitro model for assessment of the neuroprotective effects of estrogens.
    Zaulyanov LL; Green PS; Simpkins JW
    Cell Mol Neurobiol; 1999 Dec; 19(6):705-18. PubMed ID: 10456232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of a novel non-receptor-binding estrogen analogue: in vitro and in vivo analysis.
    Liu R; Yang SH; Perez E; Yi KD; Wu SS; Eberst K; Prokai L; Prokai-Tatrai K; Cai ZY; Covey DF; Day AL; Simpkins JW
    Stroke; 2002 Oct; 33(10):2485-91. PubMed ID: 12364742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and estrogenic activity of a novel estrogen receptor modulator--a hybrid structure of 17beta-estradiol and vitamin E in hippocampal neurons.
    Zhao L; Jin C; Mao Z; Gopinathan MB; Rehder K; Brinton RD
    J Med Chem; 2007 Sep; 50(18):4471-81. PubMed ID: 17696335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection and estrogen receptors.
    Simpkins JW; Singh M; Brock C; Etgen AM
    Neuroendocrinology; 2012; 96(2):119-30. PubMed ID: 22538356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's.
    Bhavnani BR
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):473-82. PubMed ID: 12943738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons.
    Zhao L; Wu TW; Brinton RD
    Brain Res; 2004 Jun; 1010(1-2):22-34. PubMed ID: 15126114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo.
    Perez E; Liu R; Yang SH; Cai ZY; Covey DF; Simpkins JW
    Brain Res; 2005 Mar; 1038(2):216-22. PubMed ID: 15757637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of 17beta-estradiol and nonfeminizing estrogens against H2O2 toxicity in human neuroblastoma SK-N-SH cells.
    Wang X; Dykens JA; Perez E; Liu R; Yang S; Covey DF; Simpkins JW
    Mol Pharmacol; 2006 Jul; 70(1):395-404. PubMed ID: 16614138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential neuroprotective effects of equine estrogens against oxidized low density lipoprotein-induced neuronal cell death.
    Berco M; Bhavnani BR
    J Soc Gynecol Investig; 2001; 8(4):245-54. PubMed ID: 11525901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17α-Estradiol: a candidate neuroserm and non-feminizing estrogen for postmenopausal neuronal complications.
    Kaur SP; Bansal S; Chopra K
    Steroids; 2015 Apr; 96():7-15. PubMed ID: 25595449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.